These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21677297)

  • 1. Quality achievement and disease prevalence in primary care predicts regional variation in renal replacement therapy (RRT) incidence: an ecological study.
    Dhoul N; de Lusignan S; Dmitrieva O; Stevens P; O'Donoghue D
    Nephrol Dial Transplant; 2012 Feb; 27(2):739-46. PubMed ID: 21677297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population?
    Castledine CI; Gilg JA; Rogers C; Ben-Shlomo Y; Caskey FJ
    Nephrol Dial Transplant; 2012 Oct; 27(10):3943-50. PubMed ID: 22778180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables.
    Visser A; Noordzij M; Gansevoort RT; Van Biesen W; Reijneveld SA; Jager KJ; de Jong PE; Izaks GJ; Dijkstra GJ; De Meester J; Hoitsma AJ; Franssen CF
    Nephrol Dial Transplant; 2012 Feb; 27(2):803-9. PubMed ID: 21669881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The delivery of renal replacement therapy in Scotland--why the geographic variation?
    Boyd J; Mackinnon MW; Severn A; Traynor JP; Whitworth CE; Metcalfe W;
    QJM; 2013 Dec; 106(12):1077-85. PubMed ID: 23974056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
    Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gap between estimated incidence of end-stage renal disease and use of therapy.
    Anand S; Bitton A; Gaziano T
    PLoS One; 2013; 8(8):e72860. PubMed ID: 24023651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in renal registries between the Balkans and Western Europe.
    Stojceva-Taneva O; Selim GJ; Zafirovska K; Polenakovic M
    Prilozi; 2006 Dec; 27(2):37-47. PubMed ID: 17211290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
    Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
    Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
    Boddana P; Caskey F; Casula A; Ansell D
    Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales.
    van Woerden HC; Wilkinson J; Heaven M; Merrifield J
    BMC Nephrol; 2007 Jan; 8():1. PubMed ID: 17217542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK Renal Registry 15th annual report: Chapter 1 UK RRT incidence in 2011: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 123 Suppl 1():1-28. PubMed ID: 23774484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of disease: Prevalence and incidence of endstage renal disease in Middle Eastern countries.
    Shaheen FAM; Al-Attar B; Ahmad MK; Follero PM
    Clin Nephrol; 2020; 93(1):120-123. PubMed ID: 31793874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.
    Comas J; Arcos E; Castell C; Cases A; Martínez-Castelao A; Doñate T; Esmatjes E
    Nephrol Dial Transplant; 2013 May; 28(5):1191-8. PubMed ID: 23147160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global variation in renal replacement therapy for end-stage renal disease.
    Caskey FJ; Kramer A; Elliott RF; Stel VS; Covic A; Cusumano A; Geue C; Macleod AM; Zwinderman AH; Stengel B; Jager KJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2604-10. PubMed ID: 21245131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International comparison of trends in patients commencing renal replacement therapy by primary renal disease.
    Stel VS; Awadhpersad R; Pippias M; Ferrer-Alamar M; Finne P; Fraser SD; Heaf JG; Hemmelder MH; Martínez-Castelao A; de Meester J; Palsson R; Prischl FC; Segelmark M; Traynor JP; Santamaria R; Reisaeter AV; Massy ZA; Jager KJ
    Nephrology (Carlton); 2019 Oct; 24(10):1064-1076. PubMed ID: 30456883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-economic status, ethnicity and geographical variations in acceptance rates for renal replacement therapy in England and Wales: an ecological study.
    Udayaraj UP; Ben-Shlomo Y; Roderick P; Casula A; Ansell D; Tomson CR; Caskey FJ
    J Epidemiol Community Health; 2010 Jun; 64(6):535-41. PubMed ID: 19854746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.